GlassScriptPhysician profile
Stephen Michigan
NPI 1760448393
$1,691.44
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,189 · 2020: $235 · 2021: $46.23 · 2022: $118 · 2023: $63.58 · 2024: $40.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $103.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $646.21 | 2019 | |
| Abbvie INC. | $228.88 | 2020-2024 | |
| Amgen INC. | $144.36 | 2019 | |
| Pfizer INC. | $133.41 | 2019-2022 | |
| Boston Scientific Corporation | $130.02 | 2019-2020 | |
| Astellas Pharma US INC | $90.63 | 2019 | |
| Coloplast Corp | $60.12 | 2019 | |
| Endo Pharmaceuticals INC. | $45.24 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.84 | 2019 | |
| Janssen Biotech, INC. | $39.72 | 2019 | |
| Ferring Pharmaceuticals INC. | $39.70 | 2019 | |
| Allergan, INC. | $31.92 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $30.23 | 2020-2021 | |
| Cook Medical LLC | $15.63 | 2021 | |
| Neotract INC. | $13.22 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $1.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Michigan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.